The EORTC phase II study of iproplatin in advanced osteogenic sarcoma [3]

European Journal of Cancer

Volumn 35, Issue 1, 1999, Pages 163-164

  Pawinski, A ^a   Crowther, D ^a   Keizer, H J ^a   Voute, P A ^a   Somers, R ^a   Van Glabbeke, M ^a   Lentz, M A ^a   Van Oosterom, A T ^a  

^a EORTC DATA CENTER   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

IPROPLATIN;

CANCER CHEMOTHERAPY; CLINICAL TRIAL; DRUG EFFICACY; DRUG RESEARCH; DRUG SCREENING; HUMAN; LETTER; OSTEOSARCOMA; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL;

ADOLESCENT; ADULT; ANTINEOPLASTIC AGENTS; BONE NEOPLASMS; CHILD; CHILD, PRESCHOOL; HUMANS; INFUSIONS, INTRAVENOUS; MIDDLE AGED; ORGANOPLATINUM COMPOUNDS; OSTEOSARCOMA;

EID: 0033061584     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0959-8049(98)00266-4     Document Type: Letter

References (7)